FDMT SG&A Expense Growth
4D Molecular Therapeutics Inc · SG&A Expense Growth
FDMT SG&A Expense Growth
Latest reported5.33%period ending
FDMT FY SG&A Growth (YoY) (0.00% → 5.33%)
Latest values, visible window
High-resolution chart · PNG
FDMT sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 5.3264% | |
| 27.6347% | |
| 10.897% | |
| 17.4824% | |
| 62.4956% | |
| 24.059% | |
| 125.3121% | |
| 76.7555% | |
| 0% |